{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:37:15Z","timestamp":1791722235744,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI050427"],"award-info":[{"award-number":["PI050427"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI060507"],"award-info":[{"award-number":["PI060507"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI020499"],"award-info":[{"award-number":["PI020499"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spanish Journal of Psychiatry and Mental Health"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.rpsm.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T18:58:55Z","timestamp":1652727535000},"page":"175-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Metabolic syndrome and related factors in a large sample of antipsychotic na\u00efve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1810-947X","authenticated-orcid":false,"given":"Nathalia","family":"Garrido-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5790-7346","authenticated-orcid":false,"given":"Miguel","family":"Ruiz-Veguilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Oliv\u00e9 Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Rodr\u00edguez Gangoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5818-5103","authenticated-orcid":false,"given":"Manuel","family":"Canal-Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-6515","authenticated-orcid":false,"given":"Mar\u00eda","family":"Juncal-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3749-3801","authenticated-orcid":false,"given":"Marcos","family":"G\u00f3mez-Revuelta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0570-5352","authenticated-orcid":false,"given":"Rosa","family":"Ayesa-Arriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0033-7132","authenticated-orcid":false,"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5478-3376","authenticated-orcid":false,"given":"Javier","family":"V\u00e1zquez-Bourgon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpsm.2022.05.003_bib0245","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0250","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Mod Mech"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.31887\/DCNS.2018.20.1\/bpenninx","article-title":"Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications","volume":"20","author":"Penninx","year":"2018","journal-title":"Dial Clin Neurosci"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0260","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ajmg.b.32712","article-title":"Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome","volume":"180","author":"Postolache","year":"2019","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0265","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00004647-199703000-00010","article-title":"Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness","volume":"17","author":"Wong","year":"1997","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0270","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0275","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0280","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/YCO.0000000000000530","article-title":"Causes of premature mortality in schizophrenia: a review of literature published in 2018","volume":"32","author":"Laursen","year":"2019","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0285","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0140-6736(19)32521-8","article-title":"Premature mortality, causes of death, and mental disorders","volume":"394","author":"Adorjan","year":"2019","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0290","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","article-title":"Excess early mortality in schizophrenia","volume":"10","author":"Laursen","year":"2014","journal-title":"Ann Rev Clin Psychol"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0295","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch Gener Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0300","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-017-4763-x","article-title":"Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naive patients with a first-episode of non-affective psychosis","volume":"235","author":"Vazquez-Bourgon","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2020.08.009","article-title":"A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: a pragmatic clinical trial in first episode psychosis patients","author":"Vazquez-Bourgon","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0310","article-title":"Treatment discontinuation impact on long-term (10-years) weight gain and lipid metabolism in first-episode psychosis: results from the PAFIP-10 cohort","author":"Vazquez-Bourgon","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0315","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40261-021-01000-1","article-title":"Second-generation antipsychotic drugs for patients with schizophrenia: systematic literature review and meta-analysis of metabolic and cardiovascular side effects","volume":"41","author":"Rognoni","year":"2021","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0320","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2008.09.028","article-title":"Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naive population","volume":"107","author":"Perez-Iglesias","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0325","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S1461145713001053","article-title":"Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors","volume":"17","author":"Perez-Iglesias","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0330","first-page":"1","article-title":"Metabolic syndrome in antipsychotic-naive patients with first-episode psychosis: a systematic review and meta-analysis","author":"Garrido-Torres","year":"2021","journal-title":"Psychol Med"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0335","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1007\/s00213-021-05983-9","article-title":"The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia","volume":"238","author":"Lang","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0340","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41380-018-0058-9","article-title":"Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models","volume":"24","author":"Pillinger","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0345","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/acps.13212","article-title":"Cardiometabolic risk prediction algorithms for young people with psychosis: a systematic review and exploratory analysis","volume":"142","author":"Perry","year":"2020","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0350","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ (Clin Res Ed.)"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0355","doi-asserted-by":"crossref","first-page":"j5019","DOI":"10.1136\/bmj.j5019","article-title":"Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study","volume":"359","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ (Clin Res Ed.)"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0360","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jamapsychiatry.2014.2133","article-title":"Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program","volume":"72","author":"Osborn","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0365","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S2215-0366(21)00114-0","article-title":"Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis","volume":"8","author":"Perry","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0370","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1751-7893.2008.00074.x","article-title":"Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis","volume":"2","author":"Pelayo-Teran","year":"2008","journal-title":"Early Interv Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0375","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rpsm.2021.01.004","article-title":"Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: rationale and design of a prospective, randomized, 3-phase, investigator-initiated study (PAFIP-3)","volume":"14","author":"Son","year":"2021","journal-title":"Revista de Psiquiatria y Salud Mental"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0380","series-title":"Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition (SCID-I\/P)","author":"First","year":"2002"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0385","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0390","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0395","series-title":"A comprehensive tool for validated entry and documentation of data","author":"Lauritsen","year":"2004"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0400","first-page":"E24","article-title":"Metabolic syndrome prevalence by race\/ethnicity and sex in the United States. National Health and Nutrition Examination Survey, 1988\u20132012","volume":"14","author":"Moore","year":"2017","journal-title":"Prevent Chronic Dis"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0405","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0410","first-page":"115","article-title":"The relation between body fat distribution and cardiovascular risk factors in patients with schizophrenia: a cross-sectional pilot study","volume":"7","author":"Kato","year":"2005","journal-title":"Primary Care Compan J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0415","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1464-5491.2004.01361.x","article-title":"Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects","volume":"21","author":"Valsamakis","year":"2004","journal-title":"Diab Med"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0420","doi-asserted-by":"crossref","first-page":"e04","DOI":"10.4088\/JCP.0208e04","article-title":"Managing weight gain and metabolic issues in patients treated with atypical antipsychotics","volume":"69","author":"Henderson","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0425","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","article-title":"Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome","volume":"37","author":"Beumer","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0430","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/07435800.2020.1811724","article-title":"Chemerin ratios to HDL-cholesterol and adiponectin as biomarkers of metabolic syndrome","volume":"45","author":"Shafer-Eggleton","year":"2020","journal-title":"Endocr Res"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0435","doi-asserted-by":"crossref","first-page":"769217","DOI":"10.3389\/fneur.2021.769217","article-title":"Monocyte\/high-density lipoprotein ratio predicts the prognosis of large artery atherosclerosis ischemic stroke","volume":"12","author":"Li","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0440","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/ATVBAHA.106.138990","article-title":"Predominance of a proinflammatory phenotype in monocyte-derived macrophages from subjects with low plasma HDL-cholesterol","volume":"27","author":"Sarov-Blat","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0445","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.schres.2018.06.039","article-title":"Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naive first episode psychosis individuals: a 3 months randomized study","volume":"202","author":"Juncal-Ruiz","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0450","doi-asserted-by":"crossref","first-page":"646701","DOI":"10.3389\/fphar.2021.646701","article-title":"Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysis","volume":"12","author":"Crespo-Facorro","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0455","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41537-019-0075-y","article-title":"Altered gene expression in antipsychotic-induced weight gain","volume":"5","author":"Crespo-Facorro","year":"2019","journal-title":"NPJ Schizophr"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0460","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/mp.2013.54","article-title":"Childhood maltreatment and obesity: systematic review and meta-analysis","volume":"19","author":"Danese","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0465","first-page":"1","article-title":"Can epigenetics shine a light on the biological pathways underlying major mental disorders?","author":"Alameda","year":"2022","journal-title":"Psychol Med"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0470","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bbi.2017.06.005","article-title":"Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses","volume":"65","author":"Aas","year":"2017","journal-title":"Brain Behav Immunity"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0475","doi-asserted-by":"crossref","first-page":"109910","DOI":"10.1016\/j.pnpbp.2020.109910","article-title":"Implications of early life stress on fetal metabolic programming of schizophrenia: a focus on epiphenomena underlying morbidity and early mortality","volume":"101","author":"Garcia-Rizo","year":"2020","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.rpsm.2022.05.003_bib0480","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0269881116645254","article-title":"BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment","volume":"30","author":"Cooper","year":"2016","journal-title":"J Psychopharmacol (Oxf, Engl)"}],"container-title":["Spanish Journal of Psychiatry and Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888989122000404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888989122000404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T02:29:26Z","timestamp":1762655366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1888989122000404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1888989122000404"],"URL":"https:\/\/doi.org\/10.1016\/j.rpsm.2022.05.003","relation":{},"ISSN":["2950-2853"],"issn-type":[{"value":"2950-2853","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome and related factors in a large sample of antipsychotic na\u00efve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort","name":"articletitle","label":"Article Title"},{"value":"Spanish Journal of Psychiatry and Mental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpsm.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEP y SEPB.","name":"copyright","label":"Copyright"}]}}